Axogen finalized its $200 million purchase of BioCircuit Technologies, adding the sutureless nerve-repair device NerveTape to its lineup.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.